Return to study ST001251 main page
MB Sample ID: SA091113
| Local Sample ID: | 17_23 _t_480 |
| Subject ID: | SU001319 |
| Subject Type: | Human |
| Subject Species: | Homo sapiens |
| Taxonomy ID: | 9606 |
| Age Or Age Range: | 19-27 |
| Weight Or Weight Range: | 58-92 |
| Height Or Height Range: | 172-190 |
| Gender: | Male |
| Human Race: | Caucasian |
| Human Trial Type: | Prospective randomized open label controlled intervention study |
| Human Medications: | None |
| Human Prescription Otc: | None |
| Human Smoking Status: | Non smoker |
| Human Alcohol Drug Use: | Not in |
| Human Nutrition: | Fasted for 12 hours before the first sample was obtained. |
| Human Inclusion Criteria: | Healthy (normal physical examination, electrocardiography, and routine laboratory values). |
| Human Exclusion Criteria: | Febrile illness during the 2 weeks before the endotoxemia experiment, taking any prescription medication, history of spontaneous vagal collapse, practicing or experience with any kind of meditation, or participation in a previous trial where LPS was administered. |
Select appropriate tab below to view additional metadata details:
Combined analysis:
| Analysis ID | AN002077 |
|---|---|
| Analysis type | MS |
| Chromatography type | Reversed phase |
| Chromatography system | Agilent 1290 |
| Column | Discovery HS F5-3 (15cm x 2.1 mm,3um) Supelco,Sigma Aldrich) |
| MS Type | ESI |
| MS instrument type | QTOF |
| MS instrument name | Agilent 6540 QTOF |
| Ion Mode | UNSPECIFIED |
| Units | relative abundance |
